Abstract
Using published in vitro data on the dependence of the percentage of apoptosis induced by the anti-cancer drug topotecan in a leukaemia cell line on the concentration of added caffeine, and a general model of competitive binding in a system containing two aromatic drugs and DNA, it has been shown to be possible to quantify the relative change in the biological effect just using a set of component concentrations and equilibrium constants of the complexation of the drugs. It is also proposed that a general model of competitive binding and parameterization of that model may potentially be applied to any system of DNA-targeting aromatic drugs under in vitro conditions. The main reasons underpinning the proposal are the general feature of the complexation of aromatic drugs with DNA and their interaction in physiological media via hetero-association.
Similar content being viewed by others
References
Allinger NL (1977) MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J Am Chem Soc 99:8127–8134
Bedner E, Du L, Traganos F, Darzynkiewicz Z (2001) Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restraining and analysis by laser scanning cytometry. Cytometry 43:38–45
Bernacki RJ, Pera P, Gambacorta P, Brun Y, Greco WR (2000) In vitro antitumour activity of 9-nitro-camptothecin as a single agent and in combination with other antitumour drugs. Ann NY Acad Sci 922:293–297
Bocian W, Kawęcki R, Bednarek E, Sitkowski J, Pietrzyk A, Williamson MP, Hansen PE, Kozerski L (2004) Multiple binding modes of the camptothecin family to DNA oligomers. Chem Eur J 10:5776–5787
Bocian W, Kawęcki R, Bednarek E, Sitkowski J, Williamson MP, Hansen PE, Kozerski L (2008) Binding of topotecan to a nicked DNA oligomer in solution. Chem Eur J 14:2788–2794
Brunger AT (1992) X-PLOR, a system for X-PLOR crystallography and NMR. Yale University, Press
Dashwood R, Guo D (1993) Antimutagenic potency of chlorophyllin in the Salmonella assay and its correlation with binding constants of mutagen-inhibitor complexes. Env Mol Mutagen 22:164–171
Davies DB, Veselkov DA, Djimant LN, Veselkov AN (2001) Hetero-association of caffeine and aromatic drugs and their competitive binding with a DNA oligomer. Eur Biophys J 30:354–366
Dezhenkova LG, Teviashova AN, Olsuf’eva EN, Treshchalin ID, Shtil’ AA, Preobrazhenskaia MN (2008) Anthracycline antibiotics and their derivatives—inhibitors of topoisomerase I. Bioorg Khim 34:430–432
Evans ND, Errington RJ, Shelley M, Feeney GP, Chapman MJ, Godfrey KR, Smith PJ, Chappell MJ (2004) A mathematical model for the in vitro kinetics of the anti-cancer agent topotecan. Math Biosci 189:185–217
Evstigneev MP (2010) DNA-binding aromatic drug molecules: physico-chemical interactions and their biological roles. Lambert Academic, Germany, p 96
Evstigneev MP, Mykhina YV, Davies DB (2005) Complexation of daunomycin with a DNA oligomer in the presence of an aromatic vitamin (B2) determined by NMR spectroscopy. Biophys Chem 118:118–127
Evstigneev MP, Khomich VV, Davies DB (2006a) Complexation of anthracycline drugs with DNA in the presence of caffeine. Eur Biophys J 36:1–11
Evstigneev MP, Evstigneev VP, Davies DB (2006b) NMR investigation of the effect of caffeine on the hetero-association of an anticancer drug with a vitamin. Chem Phys Lett 432:248–251
Evstigneev MP, Evstigneev VP, Santiago AA, Davies DB (2006c) Effect of a mixture of caffeine and nicotinamide on the solubility of vitamin (B2) in aqueous solution. Eur J Pharm Sci 28:59–66
Evstigneev MP, Rybakova KA, Davies DB (2006d) Complexation of norfloxacin with DNA in the presence of caffeine. Biophys Chem 121:84–95
Evstigneev MP, Lantushenko AO, Evstigneev VP, Mykhina YV, Davies DB (2008) Quantitation of the molecular mechanisms of biological synergism in a mixture of DNA-acting aromatic drugs. Biophys Chem 132:148–158
Hernandez Santiago AA, Andrejuk DD, Cervantes Tavera AM, Davies DB, Evstigneev MP (2009) Complexation of biologically active aromatic compounds with DNA in the presence of theophylline. J Biol Phys 35:115–126
Jorgensen W, Chaindrasekhar J, Madura J, Imprey R, Klein M (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
Kleywegt GL (1998) Dictionaries for heteros. News Uppsala Softw Fact 5:4
Lipfert J, Klijnhout S, Dekker NH (2010) Torsional sensing of small-molecule binding using magnetic tweezers. Nucleic Acids Res 38:7122–7132
Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP (2000) Mechanism of action of camptothecin. Ann NY Acad Sci 922:1–10
Mazzini S, Bellucci MC, Dallavalle S, Fraternali F, Mondelli R (2004) Mode of binding of camptothecins to double helix oligonucleotides. Org Biomol Chem 2:505–513
Munoz MA, Carmona C, Hidalgo J, Guardado P, Balon M (1995) Molecular associations of flavins with betacarbolines and related indoles. Bioorg Med Chem 3:41–47
Osowski A, Pietrzak M, Wieczorek Z, Wieczorek J (2010) Natural compounds in the human diet and their ability to bind mutagens prevents DNA-mutagen intercalation. J Toxicol Environ Health Part A 73:1141–1149
Pietrzak M, Wieczorek Z, Wieczorek J, Darzynkiewicz Z (2006) The ‘interceptor’ properties of chlorophylline measured within the three-component system: intercalator-DNA-chlorophyllin. Biophys Chem 123:11–19
Pietrzak M, Halicka HD, Wieczorek Z, Wieczorek J, Darzynkiewicz Z (2008) Attenuation of acridine mutagen ICR-191-DNA interactions and DNA damage by the mutagen interceptor chlorophyllin. Biophys Chem 135:69–75
Piosik J, Zdunek M, Kapuscinski J (2002) The modulation by xanthines of the DNA-damaging effect of polycyclic aromatic agents. Part II. The stacking complexes of caffeine with doxorubicin and mitoxantrone. Biochem Pharmacol 63:635–646
Piosik J, Ulanowska K, Gwizdek-Wisniewska A, Czyz A, Kapuscinski J, Wegrzyn G (2003) Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline. Mutat Res 530:47–57
Pizzolato JF, Saltz LB (2003) The camptothecins. Lancet 361:2235–2242
Ramu A, Mehta MM, Liu J, Turyan I, Aleksic A (2000) The riboflavin-mediated photooxidation of doxorubicin. Cancer Chemother Pharmacol 46:449–458
Streltsov S, Sukhanova A, Mikheikin A, Grokhovsky S, Zhuze A, Kudelina I, Mochalov K, Oleinikov V, Jardillier JD, Nabiev I (2001) Structural basis of topotecan-DNA recognition probed by flow linear dichroism, circular dichroism, and Raman spectroscopy. J Phys Chem B 105:9643–9652
Traganos F, Kapuscinski J, Darzynkiewicz Z (1991) Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novatrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Cancer Res 51:3682–3689
Traganos F, Kapuscinski J, Gong J, Ardelt B, Darzynkiewicz RJ, Darzynkiewicz Z (1993) Caffeine prevents apoptosis and cell-cycle effects induced by camptothecin or topotecan in HL-60 cells. Cancer Res 53:4613–4618
Veselkov AN, Evstigneev MP, Veselkov DA, Davies DB (2001) A generalized NMR-derived statistical-thermodynamical model of hetero-association of aromatic molecules in aqueous solution. J Chem Phys 115:2252–2266
Woziwodska A, Gwizdek-Wisniewska A, Piosik J (2011) Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic amines. Bioorg Chem 39:10–17
Yao S, Murali D, Seetharamulu P, Haridas K, Petluru PN, Reddy DG, Hausheer FH (1998) Topotecan lactone selectively binds to double- and single-stranded DNA in the absence of topoisomerase I. Cancer Res 58:3782–3786
Acknowledgments
Prof. David Gadian (ICH) is thanked for use of the NMR spectrometer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Evstigneev, M.P., Mosunov, A.A., Evstigneev, V.P. et al. Quantification of the interceptor action of caffeine on the in vitro biological effect of the anti-tumour agent topotecan. Eur Biophys J 40, 969–980 (2011). https://doi.org/10.1007/s00249-011-0712-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00249-011-0712-5